Clinical Trial Update: Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating loading dose versus standard dose intravenous ibandronate in patients with lung cancer and skeletal metastasis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Ibandronate (ibandronate)

Snippet

Sponsor: Chinese Society of Lung Cancer | Conditions: Lung Cancer | Phase 4 | Status: TERMINATED